Seroprevalence of human immunodeficiency virus infection among tuberculosis patients in the nylon district hospital tuberculosis treatment centre

East African Medical Journal

Volumn 85, Issue 11, 2008, Pages 529-536

  Sume, G E ^a   Etogo, D ^b   Kabore, S ^c   Gnigninanjouena, O ^b   Epome, S S ^a,b,c   Metchendje, J N ^c  

^a Regional Delegation of Public Health Littoral   (Cameroon)

^b Nylon District Hospital   (Cameroon)

^c Médecins Sans Frontiers/SUISSE ^*  (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; TUBERCULOSIS; URBAN POPULATION;

ADOLESCENT; ADULT; CAMEROON; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS; URBAN POPULATION; YOUNG ADULT;

EID: 66149140595     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning and Financing. WHO Report 2007 Geneva: WHO/HTM/TB/2007.376.
2. Corbett, E. L., Watt, C. J., Walker, N., et al. The growing burden of tuberculosis. Global trends and interaction with the HIV epidemic. Arch. Intern. Med. [serial online] 2003 [cited 2007 Mar 29]; 163: 1009-1021. Available from: URL: http://www.archinternmed.com. (Pubitemid 36548927)
3. Daley, C. L., Small, P. M., Schecter, G. F., et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment- length polymorphisms. N. Engl. J. Med. 1992; 326:231-235.
4. Boon, N. A., Colledge, N. R., Walker, B. R. and Hunter, J. A. Davidson's principles and practice of medicine. 20th ed. Edinburgh. Churchill Livingstone 2006.695-702.
5. Pozniak, A. Multidrug-resistant tuberculosis and HIV infection. Ann. NY. Acad. Sci. 2001; 953:98-105.
6. Lucas,S.B.,Hounnou,A.,Peacock,C.,etal. ThemortalityandpathologyofHIVinfectioninaWestAfricancity.AIDS1993;7:1675-1679. (Pubitemid24008849)
7. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patientsinfectedwithhumanimmunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998;47(No.): 2-78.
8. Institut National de la Statistique (INS) et ORC Macro. 2004. Enquete Demographique et de la Santé du Cameroun 2004. Calverton, Maryland, USA: INS et ORC Macro. 2004; 294-315.
9. Programme Nationale de Lutte contrelaTuberculose, Cameroun. Guide Technique pour les personnels de sante. 2nd ed. Yaounde. Union International Contre la Tuberculose et les Maladies Respiratoires; 2004. 18-19.
10. Zachariah,R.,Spielmann,M.P.,Harries,A.D.andSalaniponi,F.L. Voluntarycounseling, HIVtestingandsexualbehavioramongpatientswithtuberculosisinaruraldistrictofMala wi.Int.J.Tuberc.Lung.Dis.2002;7:65-71.(Pubitemid36427033)
11. El-Sony, A. I., Khamis, A. H., Enarson, D. A., et al. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int. J. Tuberc. Lungs. Dis. 2002; 6:1058-1066.
12. Centis, R. and Migliori, G.B. Evaluation of tuberculosis treatment results in Italy, report 1999. Monaldi. Arch. Chest. Dis. 2002; 57:297-305.
13. Chum, H. J., Obrien, R. J., Chond, T. M., Graf, P. and Reider, H. L. An epidemiological study of tuberculosis and HIV infection inTanzania, 1991-1993. AIDS 1996; 10:299-309.
14. Kiwuwa, M. S., Karamagi, C. and Mayanja, K. H. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. B.M.C Public Health [serial online] 2005 [cited 2007 Aug I]; 5: 122. Available form: URL: http://www.biomedcentral.com/14i 712458/5/122.
15. Kuaban,C.,Bercion,R.andKoulla-Shiro,S. HIVseroprevalencerateandincidenceofadverseskinreactionsinadultswithpulmonaryt uberculosisreceivingthiacetazonefreeanti-tuberculosistreatmentinYaounde, Cameroon.East.Afr.Med.J.1997;74:474-477.(Pubitemid127387162)
16. Akpaka,P.E.,Tulloch-Reid,M.,Justiz-Vaillant,A.andSmikle,M.F. PrevalenceofHumanImmunodeficiencyVirusinfectioninpatientswithpulmonarytuberc ulosisattheNationalChestHospitalinJamaica.Rex;.Panam.Salud.Publica.2006;19: 38-43.(Pubitemid44124589)
17. Harries,A.D.,Nyangulu,D.S.,Banda,H.,etal. Efficacyofanunsupervisedambulatorytreatmentregimenforsmear- negativepulmonarytuberculosisandtuberculouspleuraleffusioninMalawi.Int.J.Tuberc. Lung.Dis.1999;3:402-408.(Pubitemid29294690)
18. Noeske, J., Kuaban, C. and Cunin, P. Are smearpositive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon? Int. J. Tuberc. Lung. Dis. 2004; 8: 346-351.
19. Djouffo, L. MPH Thesis. Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Cameroon. Enquete sur la co-infection tuberculose/ VIH dans les Centres de Diagnostic et de Traitement (CDT) de la province du Littoral au cours du primier trimestre 2007.